The Technical AnalystExchange: XETRA Sector: Pharmaceuticals Industry: Drug Manufacturers—Specialty & Generic
PharmaSGP Holding SE Price, Forecast, Insider, Ratings, Fundamentals & Signals
-4.27% €22.40
Europe/Berlin / 2 mai 2024 @ 17:36
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 268.58 mill |
| EPS: | 1.250 |
| P/E: | 17.92 |
| Earnings Date: | May 14, 2024 |
| SharesOutstanding: | 11.99 mill |
| Avg Daily Volume: | 0.0005 mill |
| RATING 2024-05-02 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.54x |
| Company: PE 17.92 | sector: PE 33.16 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.46x |
| Company: PE 17.92 | industry: PE 39.15 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€18.60 (-16.95%) €-3.80 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
€ 22.09 - 23.11 ( +/- 2.25%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | €22.40 (-4.27% ) |
| Volume | 0.0026 mill |
| Avg. Vol. | 0.0005 mill |
| % of Avg. Vol | 497.35 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PSG.DE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PSG.DE
PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.